Skip to content
healthcare.dev
Get a free key

Onivyde

NDC 15054-0043, IRINOTECAN HYDROCHLORIDE, injection, powder, for solution, from Ipsen Biopharmaceuticals, Inc..

Product NDC
15054-0043
Status
Listed
Labeler
Ipsen Biopharmaceuticals, Inc.
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA207793
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/15054-0043 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE4.3 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
15054-0043-1150540043011 VIAL, SINGLE-DOSE in 1 CARTON (15054-0043-1) / 10 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c8b58efa-1820-48a4-b70d-62918fc4abfc

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=15054-0043

Use it

Look up 15054-0043 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/15054-0043 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 15054-0043. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.